Skip to content
value.today

Bioptix Diagnostics, Inc.

Formerly BIOPTIX LLC, ALPHASNIFFER LLC

Total raised
$21 M
7 rounds on record
Latest round
$2 M
Nov 2015
First round on record
Mar 2009
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Bioptix Diagnostics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2015$2 MNo. 7$2 to $10 million

Bioptix Diagnostics, Inc.: Raise no. 7, Nov 2015

Investors in this round

18 investors had bought by the notice of May 13, 2016: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Richard Whitcomb · Executive Officer, Director
  • Dmitry Akhanov · Director
  • J. William Freytag · Director
  • John Creecy · Director
  • Kyle Lefkoff · Director
  • Michael Routh · Director
  • Ron Lowy · Director
  • William Marshall · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Whitcomb, President and Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed May 13, 2016. Read the notice at the SEC.

equitySEC
Feb 2015$2 MNo. 6Under $2 million

Bioptix Diagnostics, Inc.: Raise no. 6, Feb 2015

Investors in this round

2 investors had bought by the notice of Feb 26, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Richard Whitcomb · Executive Officer, Director
  • Dmitry Akhanov · Director
  • J. William Freytag · Director
  • John Creecy · Director
  • Kyle Lefkoff · Director
  • Michael Routh · Director
  • Ron Lowy · Director
  • William Marshall · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Whitcomb, President and CEO. Source: SEC Form D, newest notice filed Feb 26, 2015. Read the notice at the SEC.

equity, optionsSEC
Jul 2014$2 MNo. 5$2 to $10 million

Bioptix Diagnostics, Inc.: Raise no. 5, Jul 2014

Investors in this round

18 investors had bought by the notice of Aug 13, 2014: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Richard Whitcomb · Executive Officer, Director
  • Dmitry Akhanov · Director
  • J. William Freytag · Director
  • John Creecy · Director
  • Kyle Lefkoff · Director
  • Michael Routh · Director
  • Ron Lowy · Director
  • William Marshall · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Whitcomb, President and CEO. Source: SEC Form D, newest notice filed Aug 13, 2014. Read the notice at the SEC.

equity, optionsSEC
Feb 2013$6 MNo. 4$2 to $10 million

Bioptix Diagnostics, Inc.: Raise no. 4, Feb 2013

Investors in this round

25 investors had bought by the notice of Mar 13, 2013: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $8 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Nolan Smith · Executive Officer
  • Richard Whitcomb · Executive Officer, Director
  • Dmitry Akhanov · Director
  • J. William Freytag · Director
  • John Creecy · Director
  • Kyle Lefkoff · Director
  • Michael Routh · Director
  • Ron Lowy · Director
  • William Marshall · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Whitcomb, President and CEO. Source: SEC Form D, newest notice filed Mar 13, 2013. Read the notice at the SEC.

equity, optionsSEC
Mar 2011$4 MNo. 3$2 to $10 million

Bioptix Diagnostics, Inc.: Raise no. 3, Mar 2011

Investors in this round

26 investors had bought by the notice of Mar 17, 2011: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $9 M offered; $5 M still to sell
Smallest investment taken
$1
What was sold
equity, other: Includes conversion of outstanding convertible promissory notes.
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Richard Whitcomb · Executive Officer, Director
  • J. William Freytag · Director
  • Kyle Lefkoff · Director
  • Ron Lowy · Director
  • William Marshall · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Whitcomb, President. Source: SEC Form D, newest notice filed Mar 17, 2011. Read the notice at the SEC.

equitySEC
Aug 2010$1 MNo. 2Under $2 million

Bioptix Diagnostics, Inc.: Raise no. 2, Aug 2010

Investors in this round

12 investors had bought by the notice of Aug 26, 2010: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered; $0 M still to sell
Smallest investment taken
$8,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Richard Whitcomb · Executive Officer, Director
  • J. William Freytag · Director
  • Mikhail Plam · Director
  • William Coleman · Director
  • William Marshall · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Whitcomb, President. Source: SEC Form D, newest notice filed Aug 26, 2010. Read the notice at the SEC.

debt, optionsSEC
Mar 2009$3 MNo. 1$2 to $10 million

Bioptix Diagnostics, Inc.: Raise no. 1, Mar 2009

Investors in this round

14 investors had bought by the notice of Jul 13, 2009: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
$25,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Richard Whitcomb · Executive Officer, Director
  • J. William Freytag · Director
  • Mikhail Plam · Director
  • William Coleman · Director
  • William Marshall · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes conversion of principal and interest under outstanding promissory notes.”

Signed by Richard Whitcomb, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Jul 13, 2009. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Bioptix Diagnostics, Inc. chose not to state its revenue in its newest notice of a funding round (May 2016).

    SEC Form D · May 2016

  • The industry group it chose in its notices: Other.

    SEC Form D · May 2016

That is all the official record says: Bioptix Diagnostics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Bioptix Diagnostics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 26 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Bioptix Diagnostics, Inc.
NameRoleNamed in
Richard WhitcombExecutive officerMay 2016
Nolan SmithExecutive officerMar 2013
Dmitry AkhanovDirectorMay 2016
J. William FreytagDirectorMay 2016
John CreecyDirectorMay 2016
Kyle LefkoffDirectorMay 2016
Michael RouthDirectorMay 2016
Richard WhitcombDirectorMay 2016
Ron LowyDirectorMay 2016
William MarshallDirectorMay 2016
Mikhail PlamDirectorAug 2010
William ColemanDirectorAug 2010